250 related articles for article (PubMed ID: 36235813)
1. Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice.
Xu RC; Miao WT; Xu JY; Xu WX; Liu MR; Ding ST; Jian YX; Lei YH; Yan N; Liu HD
Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235813
[TBL] [Abstract][Full Text] [Related]
2. [
Wang F; Zhang Z; Sun Y; Yang L; Guo T; Pan Y; Ding S; Jiang L; Liu H
Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):876-884. PubMed ID: 38862445
[TBL] [Abstract][Full Text] [Related]
3. Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
Qiao CM; Sun MF; Jia XB; Li Y; Zhang BP; Zhao LP; Shi Y; Zhou ZL; Zhu YL; Cui C; Shen YQ
Neurochem Res; 2020 Sep; 45(9):2128-2142. PubMed ID: 32556930
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
5. Sodium Butyrate Attenuates Diarrhea in Weaned Piglets and Promotes Tight Junction Protein Expression in Colon in a GPR109A-Dependent Manner.
Feng W; Wu Y; Chen G; Fu S; Li B; Huang B; Wang D; Wang W; Liu J
Cell Physiol Biochem; 2018; 47(4):1617-1629. PubMed ID: 29949795
[TBL] [Abstract][Full Text] [Related]
6. Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1.
Liu J; Wang F; Liu S; Du J; Hu X; Xiong J; Fang R; Chen W; Sun J
J Neurol Sci; 2017 Oct; 381():176-181. PubMed ID: 28991675
[TBL] [Abstract][Full Text] [Related]
7. [Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis
Gui J; Sun X; Wen S; Liu X; Qin B; Sang M
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):270-279. PubMed ID: 38501412
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease.
Hou Y; Li X; Liu C; Zhang M; Zhang X; Ge S; Zhao L
Exp Gerontol; 2021 Jul; 150():111376. PubMed ID: 33905875
[TBL] [Abstract][Full Text] [Related]
9. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis.
Wei H; Yu C; Zhang C; Ren Y; Guo L; Wang T; Chen F; Li Y; Zhang X; Wang H; Liu J
Biomed Pharmacother; 2023 Apr; 160():114308. PubMed ID: 36709599
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
11. Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model.
Chen G; Ran X; Li B; Li Y; He D; Huang B; Fu S; Liu J; Wang W
EBioMedicine; 2018 Apr; 30():317-325. PubMed ID: 29627390
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
13. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota.
Zhou X; Lu J; Wei K; Wei J; Tian P; Yue M; Wang Y; Hong D; Li F; Wang B; Chen T; Fang X
Oxid Med Cell Longev; 2021; 2021():9424582. PubMed ID: 34938384
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
[TBL] [Abstract][Full Text] [Related]
16. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.
Campolo M; Casili G; Biundo F; Crupi R; Cordaro M; Cuzzocrea S; Esposito E
Antioxid Redox Signal; 2017 Sep; 27(8):453-471. PubMed ID: 28006954
[TBL] [Abstract][Full Text] [Related]
17. Korean Red Ginseng Regulates Intestinal Tight Junction and Inflammation in the Colon of a Parkinson's Disease Mouse Model.
Jeon H; Kim HY; Bae CH; Lee Y; Kim S
J Med Food; 2020 Dec; 23(12):1231-1237. PubMed ID: 33121350
[TBL] [Abstract][Full Text] [Related]
18. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
[TBL] [Abstract][Full Text] [Related]
19. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
20. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.
Fujita A; Fujita Y; Pu Y; Chang L; Hashimoto K
Psychopharmacology (Berl); 2020 Jan; 237(1):83-92. PubMed ID: 31418048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
